Carbomycin

DB11383ExperimentalVet approvedSmall molecule

Carbomycin, also called magnamycin, is crystalline macrolide antibiotic. This antibacterial is obtained from Streptomyces halstedii and it presents a large inhibitory effect against Gram-positive bacteria and some Mycoplasma strains. The... The structure of carbomycin was generated in 1957 by Robert Woodward and later modified in 1965.

Mechanism: Pharmacologically active on 23S ribosomal RNA
Curator reviewed
Formula / weight: C₄₂H₆₇NO₁₆ · 841.9785 g/mol (avg)
Also known as: Carbomycin A · Magnamycin · Magnamycin A
Code names: M-4209 · NSC-51001 · NSC-55924

Resolves to

Compound

UNIIAIK0XUF3AVCAS4564-87-8ChEMBLCHEMBL1231649

Structure

InChIKeyFQVHOULQCKDUCY-OGHXVOSASA-NSMILES

[H][C@@]1(C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O1)O[C@@H]1[C@@H](C)O[C@@]([H])(O[C@H]2[C@@H](CC=O)C[C@@H](C)C(=O)\C=C\[C@@H]3O[C@H]3C[C@@H](C)OC(=O)C[C@@H](OC(C)=O)[C@@H]2OC)[C@H](O)[C@H]1N(C)C

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

317Drug interactionsStructured to mechanism, not free text

13+ReferencesStructured and connected to the statements they support

Which companies are running trials of Carbomycin, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account